FDA Adverse Event Injury Summary report: N

UNICEL® DXI 800 ACCESS® IMMUNOASSAY SYSTEM

MDR report key: 2866714 · Received December 10, 2012

Report

Report Number
2122870-2012-01985
Event Type
Injury
Date Received
December 10, 2012
Date of Event
November 8, 2012
Report Date
November 12, 2012
Manufacturer
BECKMAN COULTER, INC.
Product Code
DHA
PMA / PMN Number
K023764
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE FIELD SERVICE ENGINEER (FSE) PERFORMED SYSTEM CHECK AND HIGH SENSITIVITY SYSTEM CHECK, WHICH PASSED WITHIN SPECIFICATION FOR ALL PARAMETERS. THE FSE VERIFIED TOTAL BETA HUMAN CHORIONIC GONADOTROPHIN (TBHCG) PRECISION WAS WITHIN SPECIFICATION AND QUALITY CONTROL (QC) WAS WITHIN THE LABORATORY'S ESTABLISHED LIMITS. NO HARDWARE ISSUES WERE IDENTIFIED. THE UNIT CONFORMED TO THE MANUFACTURER'S PUBLISHED PERFORMANCE SPECIFICATIONS. A DEFINITIVE CAUSE OF THE EVENT IS UNKNOWN.

Description of Event or Problem · 1

THE CUSTOMER REPORTED DISCREPANT TOTAL BETA HUMAN CHORIONIC GONADOTROPHIN (TBHCG) RESULTS, FOR ONE PATIENT, INVOLVING THE UNICEL DXI 800 ACCESS IMMUNOASSAY SYSTEM. THE DISCREPANT RESULTS WERE RELEASED OUT OF THE LABORATORY AND QUESTIONED BY THE PHYSICIAN. COMPUTED TOMOGRAPHY (CT) SCAN WAS DELAYED FOR APPROXIMATELY FIVE HOURS DUE TO THE DISCREPANT RESULTS. THERE HAS BEEN NO REPORT OF CURRENT PATIENT OUTCOME TO DATE. THE CUSTOMER STATED BHCG QUALITY CONTROL (QC) HAD BEEN WITHIN SPECIFICATIONS. THE PATIENT SAMPLES WERE COLLECTED INTO A BECTON DICKINSON (BD) TOP VACUTAINER TUBE WITH GEL BARRIER. THE SAMPLES WERE CENTRIFUGED AT 3,000 RPM (ROTATIONS PER MINUTE) FOR SEVEN MINUTES, AT ROOM TEMPERATURE. BECKMAN COULTER FIELD SERVICE ENGINEER (FSE) WAS DISPATCHED TO EVALUATE THE INSTRUMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 UNICEL® DXI 800 ACCESS® IMMUNOASSAY SYSTEM ANALYZER, CHEMISTRY (PHOTOMETRIC, DISCRETE), FOR CLINICAL USE DHA BECKMAN COULTER, INC. NA NA

Patients

Seq Age Sex Outcome Treatment
1 Other